Ethylene Glycol Elimination Kinetics and Outcomes in Patients Managed Without Hemodialysis
- 30 June 2012
- journal article
- research article
- Published by Elsevier BV in Annals of Emergency Medicine
- Vol. 59 (6), 527-531
- https://doi.org/10.1016/j.annemergmed.2011.12.001
Abstract
Study objective Ethylene glycol remains an important toxic cause of metabolic acidosis and acute renal failure. Traditionally, inhibition of alcohol dehydrogenase along with hemodialysis has been used for treatment. Because of reported long elimination half-life of ethylene glycol during alcohol dehydrogenase inhibition, hemodialysis has been used in patients who are otherwise doing well to clear ethylene glycol. We study ethylene glycol elimination kinetics in patients treated with fomepizole, but without hemodialysis. Methods This was a retrospective, multicenter cohort study of patients older than 15 years who were treated at one of 3 medical centers during an 8-year period. Inclusion criteria were peak serum ethylene glycol concentration greater than 20 mg/dL, lack of renal failure on admission, treatment with fomepizole but without hemodialysis, and availability of serial serum ethylene glycol concentrations, allowing calculation of elimination half-life. The primary outcome variable was ethylene glycol elimination half-life; mortality and onset of renal failure were secondary outcome variables. Results During the study period, 85 patients were treated for ethylene glycol toxicity, of whom 40 met inclusion criteria. The mean serum ethylene glycol elimination half-life was 14.2 hours (SD=3.7 hours; 95% confidence interval 13.1 to 15.3 hours). One patient presented with metabolic acidosis on admission and developed mild transient renal insufficiency but did not require hemodialysis. No patient died. Conclusion The mean elimination half-life of ethylene glycol in this population was shorter than previously reported without hemodialysis, and this select group of patients did well without enhanced elimination by hemodialysis.Keywords
This publication has 18 references indexed in Scilit:
- 2008 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 26th Annual ReportClinical Toxicology, 2009
- Fomepizole for Ethylene Glycol and Methanol PoisoningNew England Journal of Medicine, 2009
- Ethanol: Tastes Great! Fomepizole: Less Filling!Annals of Emergency Medicine, 2009
- Adverse Drug Events Associated With the Antidotes for Methanol and Ethylene Glycol Poisoning: A Comparison of Ethanol and FomepizoleAnnals of Emergency Medicine, 2009
- Current recommendations for treatment of severe toxic alcohol poisoningsIntensive Care Medicine, 2004
- Fomepizole alone for severe infant ethylene glycol poisoningPediatric Critical Care Medicine, 2004
- Ethylene glycol intoxication: case report and pharmacokinetic perspectives.Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- Fomepizole in treatment of uncomplicated ethylene glycol poisoningThe Lancet, 1999
- Ethylene glycol poisoning treated by intravenous 4-methylpyrazoleIntensive Care Medicine, 1998
- 4-Methylpyrazole may be an alternative to ethanol therapy for ethylene glycol intoxication in manJournal of Toxicology: Clinical Toxicology, 1986